Kodiak Sciences (FRA:K27) Accounts Payable & Accrued Expense : €29.31 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Kodiak Sciences Accounts Payable & Accrued Expense?

Kodiak Sciences's quarterly accounts payable & accrued expense declined from Jun. 2023 (€61.28 Mil) to Sep. 2023 (€57.87 Mil) and declined from Sep. 2023 (€57.87 Mil) to Dec. 2023 (€29.31 Mil).

Kodiak Sciences's annual accounts payable & accrued expense declined from Dec. 2021 (€53.76 Mil) to Dec. 2022 (€40.19 Mil) and declined from Dec. 2022 (€40.19 Mil) to Dec. 2023 (€29.31 Mil).

Kodiak Sciences Accounts Payable & Accrued Expense Historical Data

The historical data trend for Kodiak Sciences's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kodiak Sciences Accounts Payable & Accrued Expense Chart

Kodiak Sciences Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

10.15

23.88

53.76

40.19

29.31

Kodiak Sciences Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															40.19	56.97	61.28	57.87	29.31

Kodiak Sciences Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Kodiak Sciences (FRA:K27) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kodiak Sciences Inc (FRA:K27) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

KOD:USA K27:Germany

Address

1200 Page Mill Road, Palo Alto, CA, USA, 94304

Website

https://www.kodiak.com

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.

Kodiak Sciences (FRA:K27) Headlines

No Headlines